University of Alabama at Birmingham: Prostatic Neoplasms trials

The registry lists 11 Prostatic Neoplasms studies with University of Alabama at Birmingham as lead sponsor. 0 are open to participants now and 6 have results posted.

Early Phase 1 1Phase 1 4Phase 2 5No phase 3(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Abemaciclib in Combination With Androgen Deprivation Therapy for Locally Advanced Prostate CancerTerminatedNCT04298983Phase 2Results posted
• PSMA-PET/MRI for Radiation Treatment Planning in Patients With Locally Metastatic Prostate Cancer: A Pilot StudyCompletedNCT04086966Phase 1Results posted
• Adapting Multiple Behavior Interventions That Effectively Improve Cancer Survivor Health Cancer Survivor HealthCompletedNCT04000880Not applicableResults posted
• RAD 1801: Pilot Study of Intra-Urethral Radiotransponder Beacon Guided Focal Prostate Stereotactic Body RadiotherapyTerminatedNCT03458234Not applicableResults posted
• Pretreatment Staging of High-Risk Prostate Cancer With 18F-Fluciclovine PET/MRICompletedNCT03264456Phase 1/2Results posted
• Phase 2 Trial of Carfilzomib for Metastatic Castration-resistant Prostate Cancer Following TreatmentCompletedNCT02047253Phase 2Results posted
• 18F-rhPSMA-7.3 PET/MRI in Prostate Cancer Active Surveillance: a Pilot StudyWithdrawnNCT05707182Early Phase 1
• Phase I Trial of PACE for Metastatic Prostate CancerWithdrawnNCT03110588Phase 1
• Improving Energy Balance in Men With Prostate CancerCompletedNCT01886677Not applicable
• Study Evaluating the Safety and Tolerability of L-377202CompletedNCT00987753Phase 1/2
• Neoadjuvant Eflornithine and Bicalutamide Compared With Eflornithine Alone, Bicalutamide Alone, and No Neoadjuvant Therapy in Treating Patients With Localized Prostate Cancer Undergoing Brachytherapy or Radical ProstatectomyCompletedNCT00086736Phase 2